Published in
Wiley, Arthritis and Rheumatology, 12(74), p. 1943-1958, 2022
DOI: 10.1002/art.42282
Links
Tools
Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three‐Year Results From a Phase IIb Randomized Controlled Trial and Its Open‐Label Extension Study
Journal article published in 2022 by
Xenofon Baraliakos 
,
Atul Deodhar ,
Maxime Dougados,
Lianne S. Gensler ,
Anna Molto,
Sofia Ramiro ,
Alan J. Kivitz,
Denis Poddubnyy ,
Marga Oortgiesen,
Thomas Vaux,
Carmen Fleurinck,
Julie Shepherd‐Smith,
Christine de la Loge,
Natasha de Peyrecave,
Désirée van der Heijde
,
Atul Deodhar ,
Maxime Dougados,
Lianne S. Gensler ,
Anna Molto,
Sofia Ramiro ,
Alan J. Kivitz,
Denis Poddubnyy ,
Marga Oortgiesen,
Thomas Vaux,
Carmen Fleurinck,
Julie Shepherd‐Smith,
Christine de la Loge,
Natasha de Peyrecave,
Désirée van der Heijde
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 